Daiichi Pharmaceutical Co., Ltd.:
Daiichi Pharmaceutical Co., Ltd., established in 1915, has
grown as a research and development based organization, ensuring its leading
position as a developer of advanced pharmaceutical products and health
care related chemicals. Daiichi contribute to the pharmaceutical society
by enriching the quality of life.
The products and R&D activities in the anti-infectives domain are
ofloxacin and levofloxacin, broad-spectrum antibacterial agents, highly
valued throughout the world today and pre-clinical research into next-generation
quinolone drugs.
|
